| Literature DB >> 19665696 |
Takemi Oguma1, Takeshi Ono, Toshimitsu Kajiwara, Masaki Sato, Yasushi Miyahira, Hiroshi Arino, Yasuo Yoshihara, Takushi Tadakuma.
Abstract
When the CD4(+)CD8(+) thymic lymphoma cells were treated with puromycin, we found that most of the cells died at 0.3-1 microg/ml of puromycin within 24h. However, cell death was greatly reduced when the dose of puromycin was increased. Similar dose-pattern of cell death was observed in thymocytes and the sensitivity to puromycin was greater in CD4(+)CD8(+) thymocytes than CD4(+)CD8(-) thymocytes. The induction of apoptosis was blocked by the protein synthesis inhibitor cycloheximide, and to some extent by transfection of Bcl-xL or Bcl-2 genes. Expression of GRP78 was up-regulated after treatment with a small dose of puromycin, and the cell death by puromycin was blocked in the presence of caspase 12 inhibitor. These results indicated that the induction of cell death by low-dose puromycin was due to endoplasmic reticulum stress. Furthermore, we found that dexamethasone, a synthetic glucocorticoid, and puromycin worked synergistically to induce cell death in thymocytes.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19665696 DOI: 10.1016/j.cellimm.2009.07.002
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.868